Prot# MCB 0501 INT: Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (aged 12 to 17 years) With Psoriasis Vulgaris

Project: Research project

Project Details

StatusFinished
Effective start/end date5/28/09 → 5/28/15

Funding

  • Health Decisions Inc. (MCB 0501 INT // MCB 0501 INT)
  • LEO Pharma A/S (MCB 0501 INT // MCB 0501 INT)